TEZSPIRE Commercial United States

Ad Creative: Explore How TEZSPIRE tezepelumabekko May Help

TEZSPIRE Explore How TEZSPIRE tezepelumabekko May Help Ad Commercial Brand Imagery Photoshoot 0
TEZSPIRE Explore How TEZSPIRE tezepelumabekko May Help Ad Commercial Brand Imagery Photoshoot 1
TEZSPIRE Explore How TEZSPIRE tezepelumabekko May Help Ad Commercial Brand Imagery Photoshoot 2

TEZSPIRE Ad Profile

  • Advertising Market: United States
  • Advertiser Industry: Health
  • Advertiser Category: Asthma
  • Ad Launch Date: 2023-02-24
  • Ad Format: 30 seconds
  • Ad Description: Explore How TEZSPIRE tezepelumabekko May Help

TEZSPIRE Ad Transcript

Creative storyline based on voiceover.

  • 00:00 - no matter what type of severe asthma you
  • 00:02 - have to Aspire can help you have fewer
  • 00:04 - asthma attacks and breathe better
  • 00:05 - tespire is an add-on treatment for
  • 00:07 - people 12 and over it is not a rescue
  • 00:09 - medication don't take test fire if
  • 00:11 - you're allergic to it allergic reactions
  • 00:12 - may occur and can be serious rash or eye
  • 00:15 - allergy can happen don't stop your
  • 00:16 - asthma treatments unless your doctor
  • 00:18 - tells you to tell your doctor if you
  • 00:20 - have a parasitic infection or your
  • 00:21 - asthma worsens sore throat joint and
  • 00:23 - back pain may occur avoid live vaccines
  • 00:25 - no matter who you are ask your asthma
  • 00:28 - specialist about to Aspire today

TEZSPIRE Ad Visuals

Visual objects featured in the creative imagery.

TEZSPIRE Ad Reach

Audience reach based on YouTube views benchmarked against Market, Industry and Category.

  Medium vs. United States

  Medium vs. Health

  Medium vs. Asthma

TEZSPIRE Ad Favorability

Creative favorability based on YouTube likes benchmarked against Market, Industry and Category.

  Medium vs. United States

  Medium vs. Health

  High vs. Asthma

TEZSPIRE Ad Engagement

Audience engagement based on YouTube comments benchmarked against Market, Industry and Category.

  No Data

  No Data

  No Data